{"id":"NCT03019575","sponsor":"Organon and Co","briefTitle":"Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)","officialTitle":"A Phase III, Multi-Center, Open Label, Single-Group Trial to Investigate the Efficacy and Safety of MK-8962 (Corifollitropin Alfa) in Combination With Human Chorionic Gonadotropin (hCG) for Initiation or Restoration of Puberty as Assessed by Increased Testicular Volume in Adolescent Males 14 to <18 Years Old With Hypogonadotropic Hypogonadism (MK-8962-043)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-02-02","primaryCompletion":"2020-05-05","completion":"2020-05-05","firstPosted":"2017-01-12","resultsPosted":"2021-04-08","lastUpdate":"2024-05-23"},"enrollment":17,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypogonadotropic Hypogonadism"],"interventions":[{"type":"DRUG","name":"Corifollitropin alfa","otherNames":["MK-8962","Elonva"]},{"type":"DRUG","name":"hCG","otherNames":[]}],"arms":[{"label":"Corifollitropin alfa (CFA)+human Chorionic Gonadotropin (hCG)","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to investigate whether corifollitropin alfa (MK-8962), administered alone for 12 weeks and then in combination with human chorionic gonadotropin (hCG) for 52 weeks, increases the testicular volume in adolescent males aged 14 to \\<18. In addition, the study will evaluate participants for safety, tolerability and for the development of corifollitropin alfa antibodies. No formal hypothesis will be tested for this estimation study","primaryOutcome":{"measure":"Change From Baseline in Log-Transformed Testicular Volume (TV) to Week 64","timeFrame":"Baseline and Week 64","effectByArm":[{"arm":"Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG)","deltaMin":1.5,"sd":0.7}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"14 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":15,"countries":["Brazil","Denmark","Italy","Mexico","Russia","South Africa"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":17},"commonTop":["Oestradiol increased","Spermatocele","Blood testosterone increased","Headache","Diarrhoea"]}}